The examination of the second-level tertiary public hospital came and strictly controlled the hospital's medication.

Medical Network June 11th, the second and third-level hospitals, the assessment came on June 9, the National Health and Care Commission issued "on the collection of second- and third-level public hospitals 2019 annual performance appraisal data related to the work of the notice."
According to the notice, each three-level public hospital should report data on the performance appraisal management platform of the public hospital from June 12 to June 19, 2020The provincial health and health committees shall complete the online audit of the data filled in by the tertiary public hospitals by June 26, 2020 to ensure the authenticity and integrity of the data reported by the hospital.
The level 2 public hospitals participating in the 2019 Performance Review should report the data on the management platform from July 20 to August 5, 2020The provincial health and health committees shall complete the online audit of the data filled in by the second-level public hospitals by September 6, 2020, so as to ensure the authenticity and integrity of the data reported by the hospital.
In addition to the special instructions, the annual data in the quantitative indicators are reported from 1 January to 31 December of that year.
The notice is clear, it is strictly prohibited to fabricate, falsely report, underreport data and other circumstancesThe National Health and Health Commission will work with the relevant departments to organize experts to review and analyze the data, and seriously deal with the units and individuals that have deliberately fabricated, misrepresented, concealed and other violations of discipline in the course of the examination.
Strict drug control proportion From the National Health and Care Commission issued by the second- and third-level hospital public hospital performance appraisal operation manual (2020 version), all mentioned the requirementof drug revenue ratio.
"National second-level public hospital performance appraisal operation manual (2020)" requires that the second-level hospitals to statistics "key monitoring drug revenue ratio": "National third-level public hospital performance appraisal operation manual (2020 version)" requirements, tertiary hospitals to statistics "auxiliary drug revenue ratio": Although one is a key monitoring drugs, one is auxiliary drugs, but in fact, the content of these two statistics is the same, are for the provinces in the first batch of national key monitoring of the rational drug catalog of drugs.
From this point of view, the range of varieties of hospital performance appraisal statistics in different provinces may be different.
On July 1, 2019, the State Health and Care Commission officially released the First Batch of State Key State Key Monitoring and Rational Drug Use Drugs Catalog (Chemical Drugs and Biological Products)According to the notice, in order to implement the Opinions of the General Office of the State Council on Strengthening the Performance Evaluation of Three-Level Public Hospitals and the Notice of the National Health And Health Administration on The Management of Clinical Application of Complementary Drugs, the National Health and Health Administration, together with the State Administration of Traditional Chinese Medicine, has formed the first batch of national key monitoring catalogues on the basis of the provincial recommended catalogues submitted by various localities.
Through the above content we can find that the first batch of national key monitoring directory and auxiliary drug catalog has a certain connection, but it is not the same as auxiliary drug catalog.
According to the Minnet database, the 20 varieties will have sales of 65.28 billion yuan in 2018 in China's public hospitalsBut the first batch of national key monitoring catalogues will not be officially launched until July 2019, and it is not good to say how much the size of these varieties can go in 2019.
In addition, according to the "Notice of the Leading Group of the State Council on Deepening the Reform of the Medical and Health System of the State Council on Further Promotion of the Experience of Deepening the Reform of the Medical and Health System in Fujian Province and Sanming City" issued by the State Council on November 15, 2019, it is clearly requested that by the end of December 2019, provinces should formulate and issue a catalogue of provincial-level key monitoring and rational drug use (chemical and biological products) and announce that a key drug monitoring mechanism should be fully established by the end of December 2020.
From this point of view, the provinces issued a key monitoring directory of different time, statistics out of the focus of monitoring drugs / auxiliary drug revenue ratio is estimated to be different.
However, it is worth paying attention to, the state to strengthen the clinical application management of auxiliary drug use, is to implement the task of deepening the reform of the medical and health system, control the unreasonable growth of medical expenses in public hospitals, but also to reduce the burden of patients to see a doctor, safeguard the people's health rights and interests of an important measureThis requirement is not temporary, but will be so strict, strict control of reasonable drug use and medical insurance fees.
The National Health and Health Administration also issued the "First Batch of State Key Monitoring of Rational Drug Use Drugs Catalog (Chemical Drugs and Biological Products)" when it said that it will work with the State Administration of Traditional Chinese Medicine to make dynamic adjustments to the Directory.
I haven't found you this year, next year is not necessarily.
Antibacterial drugs, the most stringent requirements came on June 9, the National Health and Care Commission issued "on the new situation to do a good job in the management of the clinical application of antimicrobial drugs notice (draft for comments) public consultation announcement."
The opinion draft continuously promotes the rational use of antimicrobial drugs from the aspects of optimizing the supply catalogue of antimicrobial drugs and strengthening the management of key links.
In order to optimize the inventory of antimicrobial drugs, medical institutions are required to optimize the list of antimicrobial supply in the context of the "1 plus X" drug use model, which is dominated by essential drugs ("1" is the national essential drug catalogue and "X" is non-essential drugs)When formulating the catalogue and prescription set of antimicrobial drugs supply of this institution, in addition to ensuring the specifications of the varieties in accordance with the provisions, the selection of similar drugs shall be selected with safe, effective, economical and evidence-based varieties.
To strengthen the management of key links, we should continue to promote the management of key antimicrobial drugs, focusing on preventive use, joint use and intravenous infusion, intrauterine injection, joint injection of antimicrobial drugsConditional medical institutions are encouraged to carry out monitoring of the concentration of therapeutic drugs for key antimicrobial drugs and guide clinical precision drug use.
In other words, in addition to the above-mentioned focus monitoring catalog, in the future every hospital will have to select the hospital's antimicrobial supply catalog, into this catalog is very important for antimicrobials, especially injection-type antimicrobials.
From the National Health and Care Commission issued the second- and third-level hospital performance appraisal operation manual (2020 version), also mentioned the use of antimicrobial requirements.
"National three-level public hospital performance appraisal operation manual (2020 version)" requires that the third-level hospitals to statistics "antibacterial drug use intensity (DDDs):" "National second-level public hospital performance evaluation operation manual (2020 version)" also requires that the second-level hospitals to statistics "antimicrobial drug use strength (DDDs):": there are experts on The biggest clinical problem, in fact, the proportion of drug problems, but the phenomenon of serious use of drugsFor example, some pharmaceutical companies in the promotion process will be short half-life, for the urgent and severe anti-bacterial drugs, pushed into a broad spectrum antibacterial "god medicine", resulting in the indiscriminate use of antimicrobial drugs, abuse of the situationUnder the new performance appraisal, some falsely advertised broad-spectrum antibacterial drugs, hospital medication will be obviously limited.
The industry generally believes that, compared with the simple drug ratio assessment, the current hospital performance appraisal can effectively promote rational drug use, more able to control those known as "golden oil" "god medicine."